Skip to main content
TipRanks
Go Ultimate75% OFF

Silence Therapeutics (SLN) Ratios

395 Followers

Silence Therapeutics Ratios

SLN's free cash flow for Q3 2026 was £-12.75M. For the 2026 fiscal year, SLN's free cash flow was decreased by £-3.00 and operating cash flow was £-12.75M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio8.7211.144.624.415.69
Quick Ratio8.7211.144.624.415.69
Cash Ratio0.837.213.082.504.85
Solvency Ratio-1.27-0.82-0.44-0.58-0.44
Operating Cash Flow Ratio-4.57-4.02-1.76-2.600.61
Short-Term Operating Cash Flow Coverage0.000.00-172.590.000.00
Net Current Asset ValueÂŁ 49.52MÂŁ 94.90MÂŁ 5.70MÂŁ 11.26MÂŁ -1.33M
Leverage Ratios
Debt-to-Assets Ratio0.000.000.000.000.00
Debt-to-Equity Ratio0.000.000.020.020.02
Debt-to-Capital Ratio0.000.000.020.020.02
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio2.111.515.434.8711.28
Debt Service Coverage Ratio0.000.00-163.11-1300.68-4871.88
Interest Coverage Ratio0.000.00-1458.94-1298.72-5726.75
Debt to Market Cap0.000.000.000.000.00
Interest Debt Per Share0.010.010.030.050.00
Net Debt to EBITDA0.131.981.370.901.62
Profitability Margins
Gross Profit Margin61.54%72.70%59.34%37.83%39.94%
EBIT Margin-15849.91%-114.62%-198.13%-281.87%-369.30%
EBITDA Margin-15750.63%-113.25%-196.17%-279.12%-365.86%
Operating Profit Margin-16055.99%-146.38%-195.48%-281.87%-369.02%
Pretax Profit Margin-15849.91%-102.79%-198.27%-229.26%-369.36%
Net Profit Margin-15851.88%-104.74%-170.51%-232.44%-317.44%
Continuous Operations Profit Margin-15851.88%-104.74%-170.51%-232.44%-317.44%
Net Income Per EBT100.01%101.90%86.00%101.39%85.94%
EBT Per EBIT98.72%70.22%101.42%81.33%100.09%
Return on Assets (ROA)-67.42%-27.98%-36.22%-46.82%-40.97%
Return on Equity (ROE)-142.23%-42.31%-196.73%-228.04%-462.23%
Return on Capital Employed (ROCE)-76.17%-42.64%-51.08%-71.34%-56.54%
Return on Invested Capital (ROIC)-76.11%-42.62%-43.83%-70.97%-48.51%
Return on Tangible Assets-73.52%-29.39%-39.66%-50.75%-44.49%
Earnings Yield-92.57%-53.46%-25.62%-37.20%-7.53%
Efficiency Ratios
Receivables Turnover0.022.011.0623.6737.51
Payables Turnover0.054.003.084.231.83
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover0.3227.4110.999.846.39
Asset Turnover0.000.270.210.200.13
Working Capital Turnover Ratio0.000.400.330.300.20
Cash Conversion Cycle8586.7190.12226.46-70.95-189.27
Days of Sales Outstanding16071.75181.43344.8915.429.73
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding7485.0591.30118.4486.38199.00
Operating Cycle16071.75181.43344.8915.429.73
Cash Flow Ratios
Operating Cash Flow Per Share-3.96-3.51-3.18-5.320.31
Free Cash Flow Per Share-3.96-3.52-3.19-5.370.25
Dividend Paid and CapEx Coverage Ratio-1132.20-320.57-874.44-104.675.10
Capital Expenditure Coverage Ratio-1132.20-320.57-874.44-104.675.10
Operating Cash Flow Coverage Ratio-389.19-578.12-113.73-127.9067.05
Operating Cash Flow to Sales Ratio-111.40-1.25-1.55-2.630.74
Free Cash Flow Yield-65.11%-63.97%-23.33%-42.57%1.41%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-1.07-2.32-3.90-2.69-13.28
Price-to-Sales (P/S) Ratio171.241.966.656.2542.15
Price-to-Book (P/B) Ratio1.540.797.686.1361.38
Price-to-Free Cash Flow (P/FCF) Ratio-1.54-1.56-4.29-2.3570.86
Price-to-Operating Cash Flow Ratio-1.54-1.57-4.29-2.3756.98
Price-to-Earnings Growth (PEG) Ratio-0.010.070.45-0.01-0.65
Enterprise Value Multiple-0.960.25-2.02-1.34-9.91
Enterprise Value84.61M-12.10M100.43M80.92M449.95M
EV to EBITDA-0.960.25-2.02-1.34-9.91
EV to Sales151.35-0.283.963.7436.24
EV to Free Cash Flow-1.360.22-2.55-1.4160.93
EV to Operating Cash Flow-1.360.22-2.55-1.4248.98
Tangible Book Value Per Share3.266.440.941.280.03
Shareholders’ Equity Per Share3.966.951.782.060.29
Tax and Other Ratios
Effective Tax Rate-0.00-0.020.14-0.010.14
Revenue Per Share0.042.812.052.020.42
Net Income Per Share-5.63-2.94-3.50-4.69-1.33
Tax Burden1.001.020.861.010.86
Interest Burden1.000.901.000.811.00
Research & Development to Revenue121.201.571.732.012.48
SG&A to Revenue39.970.620.811.191.61
Stock-Based Compensation to Revenue14.440.240.510.590.94
Income Quality0.701.870.781.13-0.15

Currency in GBP